Mao Mao, Varadarajan Sudhahar, Fukai Tohru, Bakhshi Farnaz R, Chernaya Olga, Dudley Samuel C, Minshall Richard D, Bonini Marcelo G
Department of Medicine-Section of Cardiology, University of Illinois at Chicago, Chicago, Illinois, United States of America; Department of Pharmacology, University of Illinois at Chicago, Chicago, Illinois, United States of America; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Department of Medicine-Section of Cardiology, University of Illinois at Chicago, Chicago, Illinois, United States of America; Department of Pharmacology, University of Illinois at Chicago, Chicago, Illinois, United States of America.
PLoS One. 2014 Aug 26;9(8):e104101. doi: 10.1371/journal.pone.0104101. eCollection 2014.
Nitrate tolerance developed after persistent nitroglycerin (GTN) exposure limits its clinical utility. Previously, we have shown that the vasodilatory action of GTN is dependent on endothelial nitric oxide synthase (eNOS/NOS3) activity. Caveolin-1 (Cav-1) is known to interact with NOS3 on the cytoplasmic side of cholesterol-enriched plasma membrane microdomains (caveolae) and to inhibit NOS3 activity. Loss of Cav-1 expression results in NOS3 hyperactivation and uncoupling, converting NOS3 into a source of superoxide radicals, peroxynitrite, and oxidative stress. Therefore, we hypothesized that nitrate tolerance induced by persistent GTN treatment results from NOS3 dysfunction and vascular toxicity. Exposure to GTN for 48-72 h resulted in nitrosation and depletion (>50%) of Cav-1, NOS3 uncoupling as measured by an increase in peroxynitrite production (>100%), and endothelial toxicity in cultured cells. In the Cav-1 deficient mice, NOS3 dysfunction was accompanied by GTN tolerance (>50% dilation inhibition at low GTN concentrations). In conclusion, GTN tolerance results from Cav-1 modification and depletion by GTN that causes persistent NOS3 activation and uncoupling, preventing it from participating in GTN-medicated vasodilation.
持续暴露于硝酸甘油(GTN)后产生的硝酸酯耐受性限制了其临床应用。此前,我们已经表明GTN的血管舒张作用依赖于内皮型一氧化氮合酶(eNOS/NOS3)的活性。已知小窝蛋白-1(Cav-1)在富含胆固醇的质膜微区(小窝)的细胞质侧与NOS3相互作用,并抑制NOS3的活性。Cav-1表达缺失会导致NOS3过度活化和解偶联,使NOS3转化为超氧自由基、过氧亚硝酸盐和氧化应激的来源。因此,我们推测持续GTN治疗诱导的硝酸酯耐受性是由NOS3功能障碍和血管毒性引起的。暴露于GTN 48 - 72小时导致Cav-1的亚硝化和耗竭(>50%),过氧亚硝酸盐生成增加(>100%)表明NOS3解偶联,以及培养细胞中的内皮毒性。在Cav-1缺陷小鼠中,NOS3功能障碍伴随着GTN耐受性(在低GTN浓度下舒张抑制>50%)。总之,GTN耐受性是由GTN对Cav-1的修饰和耗竭引起的,导致NOS3持续活化和解偶联,使其无法参与GTN介导的血管舒张。